Lack of adequate infrastructure and standardization can hamper the growth of the temperature controlled pharmaceutical containers market in emerging economies. While the demand for temperature sensitive drugs is increasing due to the rising income levels and awareness, lack of proper cold chain facilities hampers the last mile delivery of such products. This limits the effective distribution of biologics, vaccines and other drugs that require temperature control during transport and storage. Absence of standardized protocols for monitoring, tracking and validation of shipment conditions from manufacturing to the patient also reduces supply chain efficiency and trust in these markets.
Market Opportunity – Increasing Inorganic Growth Strategies by Key Market Players
Increasing adoption of inorganic growth strategies, such as agreement, is expected to offer lucrative growth opportunities for the market growth over the forecast period. For instance, in November 2022, Sonoco ThermoSafe, a unit of Sonoco and one of the largest global providers of temperature assurance packaging, and LATAM Cargo, an international cargo airline, announced a global lease agreement for the new Pegasus ULD temperature-controlled bulk shipping container.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients